WS #11595
Vertex Pharmaceuticals agreed to acquire Crinetics for $85/share (~$10B), sending CRNX up ~99% and highlighting M&A in biotech.
Vertex Acquires Crinetics Pharmaceuticals
Vertex Pharmaceuticals agreed to acquire Crinetics for $85/share (~$10B), sending CRNX up ~99% and highlighting M&A in biotech.